Company Filing History:
Years Active: 2021
Title: Vincent Lombardi: Innovator in Allergy Immunotherapy
Introduction
Vincent Lombardi is a notable inventor based in Antony, France. He has made significant contributions to the field of allergy immunotherapy, holding 2 patents that focus on predictive biomarkers for treatment efficacy.
Latest Patents
His latest patents include "IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy." This invention concerns the use of IL-10 as a biological marker for predicting the responsiveness of a house dust mite allergic patient to allergen immunotherapy. Another important patent is "Sialylated fetuin-A as a marker of immunotherapy efficacy," which identifies specific polypeptides and their variants that can serve as markers for the efficacy of immunotherapy, particularly in predicting patient responsiveness.
Career Highlights
Vincent Lombardi is associated with Stallergenes, a company dedicated to developing innovative treatments for allergies. His work has been instrumental in advancing the understanding of immunotherapy and its effectiveness.
Collaborations
He has collaborated with notable colleagues such as Véronique Bodo and Philippe Moingeon, contributing to the collective knowledge and advancements in the field of allergy treatment.
Conclusion
Vincent Lombardi's innovative work in allergy immunotherapy has paved the way for more effective treatments, showcasing the importance of research and development in improving patient outcomes.